Skip to content

Clinical trials

Phase 2/3 Bone Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Phase: Phase 2/3 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20101
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status2
Completed1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blokhin's Russian Cancer Research Center1
Emory University1
The University of Texas Health Science Center at San Antonio1
University of Roma La Sapienza1
Universität Duisburg-Essen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms5
Lung Neoplasms1
Neoplasm Metastasis1
Neoplasms, Connective Tissue1
Neoplasms, Connective and Soft Tissue1
Osteoma, Osteoid1
Osteosarcoma1
Prostatic Neoplasms1
Sarcoma1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.